EUVIMEDEUVIMED entdecken
ÜbersichtsarbeitOpen Access · CC BY 4.0

A Review and Future Perspective on Renal Outcome Definitions in Lupus Nephritis

Ioannis Parodis iD, Tina Kochar, Frank Cortazar, Yoshiya Tanaka, Nehad Soloman

ACR Open Rheumatology · 2026-07 · 8 (7)

DOI: 10.1002/acr2.90099 ↗

Kurz gefasst

Übersichtsarbeit in der Zeitschrift ACR Open Rheumatology, online erschienen am 15.07.2026. Verfasst von Ioannis Parodis und 4 weiteren Autor:innen. Beteiligte Einrichtung: Division of Rheumatology, Department of Medicine Solna, Karolinska Institutet, Karolinska University Hospital, Stockholm, Sweden. Die Arbeit nennt 73 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Aurinia Pharmaceuticals, Edmonton, Alberta, Canada.

AbstractBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Lupus nephritis (LN) remains a leading cause of morbidity and mortality in systemic lupus erythematosus, yet the lack of standardized definitions for renal outcomes hinders effective diagnosis, prognosis, treatment personalization, comparisons across trials, and interpretable trial endpoints. Despite significant advances in biomarker discovery, treatment strategies, and histopathological classification, substantial challenges and controversies persist in defining and assessing renal response to therapy. Following a January 2025 roundtable discussion on the subject of LN outcome definitions, a workgroup was established to address these issues and provide an expert perspective on the future of outcome definitions based on current literature. Here, we examine the current limitations of renal outcome definitions and advocate for change toward improved interpretation and comparison of clinical study data. Key areas, such as limitations of traditional kidney function markers and the need for reliable endpoints reflecting improvements in renal inflammation in trials, are addressed. As an international workgroup of rheumatologists and nephrologists with experience in managing LN, we advocate for a unified approach considering standard per‐protocol repeat biopsies for histologic response evaluation, estimated glomerular filtration rate slope, glucocorticoid minimization/withdrawal, and extended follow‐up for the evaluation of sustained long‐term outcomes. The importance of harmonizing clinical and histologic definitions and the potential of novel biomarkers are highlighted. Herein, we provide a perspective toward uniform definitions of response in LN trials, renal flare/relapse, and refractory disease with improved applicability, especially in the context of advanced immunosuppressives. Thereby, we aim to facilitate meaningful study and advanced treatment of LN, ultimately enhancing patient outcomes and future research.

Autor:innen und Institutionen

  • Division of Rheumatology, Department of Medicine Solna, Karolinska Institutet, Karolinska University Hospital, Stockholm, Sweden.
  • Center for Molecular Medicine, Stockholm, Sweden.
  • Department of Rheumatology, Faculty of Medicine and Health, Örebro University, Orebro, Sweden.
  • Glomerular Disease Program, Department of Internal Medicine, University of Texas Medical Branch, Galveston.
  • St. Peter's Hospital, Albany, New York.
  • New York Nephrology Vasculitis and Glomerular Center, Albany.

ORCID-Profile: Ioannis Parodis

Förderung

  • Aurinia Pharmaceuticals, Edmonton, Alberta, Canada

Zitieren

APA

Parodis, I., Kochar, T., Cortazar, F., Tanaka, Y., & Soloman, N. (2026). A Review and Future Perspective on Renal Outcome Definitions in Lupus Nephritis. ACR Open Rheumatology, 8(7). https://doi.org/10.1002/acr2.90099

Vancouver

Parodis I, Kochar T, Cortazar F, Tanaka Y, Soloman N. A Review and Future Perspective on Renal Outcome Definitions in Lupus Nephritis. ACR Open Rheumatology. 2026;8(7). doi:10.1002/acr2.90099

BibTeX
@article{Parodis2026,
  author = {Parodis, Ioannis and Kochar, Tina and Cortazar, Frank and Tanaka, Yoshiya and Soloman, Nehad},
  title = {A Review and Future Perspective on Renal Outcome Definitions in Lupus Nephritis},
  journal = {ACR Open Rheumatology},
  year = {2026},
  volume = {8},
  number = {7},
  doi = {10.1002/acr2.90099}
}
Kostenlos starten →